首页 > 最新文献

Pakistan Journal of Medical Sciences最新文献

英文 中文
Clinical profile and management of non-tubal ectopic pregnancy: Experience from a tertiary care hospital in the United Arab Emirates (UAE). 非输卵管异位妊娠的临床概况和管理:阿拉伯联合酋长国(UAE)一家三级医院的经验。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8584
Shumaila Aftab Khan, Shaba Molvi, Giya Mathew, Muna Khalfan

Objective: To study the clinical profile and management outcomes of non-tubal ectopic pregnancy at a tertiary care hospital in the United Arab Emirates (UAE).

Methods: Case files of non-tubal ectopic pregnancy (NTEP) patients from October 2017 to October 2020 presented to Alqasmi Women and Children's Hospital, Sharjah, were included in the study. The data was extracted from available medical records.

Results: A total of 30 confirmed cases of NTEP were identified with the following break-up: caesarean scar ectopic pregnancy (n=14; 46.7%), cornual pregnancy (n=11; 36.7%), cervical pregnancy (n=3; 10%) and ovarian pregnancy n=2; 6.7%). Abdominal pain was the most common presenting symptom, present in 23 (76.7% patients) followed by vaginal bleeding in 17 (56.7%) patients. Ten women were managed medically, ten required surgical treatment, and eight were managed with combined medical and surgical treatments; Two patients were managed expectantly. Patients in each treatment strategy did well and there were no deaths. One patient in the medical treatment group developed complications after one month and underwent subtotal hysterectomy.

Conclusion: Patients with NTEP were presented with varying symptoms and signs depending upon the location of NTEP. The different currently available management options for NTEP seem to be effective and safe when carefully selected based on the clinical merits of each case.

目的研究阿拉伯联合酋长国(UAE)一家三级医院非输卵管异位妊娠的临床概况和管理结果:研究纳入了 2017 年 10 月至 2020 年 10 月期间在沙迦 Alqasmi 妇女儿童医院就诊的非输卵管异位妊娠(NTEP)患者的病例档案。数据从现有病历中提取:共发现30例确诊的NTEP病例,其分类如下:剖腹产疤痕异位妊娠(14例;46.7%)、粟粒妊娠(11例;36.7%)、宫颈妊娠(3例;10%)和卵巢妊娠(2例;6.7%)。腹痛是最常见的症状,有 23 名患者(76.7%)出现腹痛,其次是阴道出血,有 17 名患者(56.7%)出现阴道出血。10 名妇女接受了药物治疗,10 名妇女需要手术治疗,8 名妇女接受了药物和手术联合治疗;2 名患者接受了期待治疗。每种治疗策略的患者均表现良好,无死亡病例。药物治疗组的一名患者在一个月后出现并发症,接受了子宫次全切除术:结论:NTEP 患者的症状和体征因 NTEP 的部位而异。根据每个病例的临床表现,谨慎选择不同的治疗方案,目前可用于治疗 NTEP 的方案似乎都是有效和安全的。
{"title":"Clinical profile and management of non-tubal ectopic pregnancy: Experience from a tertiary care hospital in the United Arab Emirates (UAE).","authors":"Shumaila Aftab Khan, Shaba Molvi, Giya Mathew, Muna Khalfan","doi":"10.12669/pjms.40.9.8584","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8584","url":null,"abstract":"<p><strong>Objective: </strong>To study the clinical profile and management outcomes of non-tubal ectopic pregnancy at a tertiary care hospital in the United Arab Emirates (UAE).</p><p><strong>Methods: </strong>Case files of non-tubal ectopic pregnancy (NTEP) patients from October 2017 to October 2020 presented to Alqasmi Women and Children's Hospital, Sharjah, were included in the study. The data was extracted from available medical records.</p><p><strong>Results: </strong>A total of 30 confirmed cases of NTEP were identified with the following break-up: caesarean scar ectopic pregnancy (n=14; 46.7%), cornual pregnancy (n=11; 36.7%), cervical pregnancy (n=3; 10%) and ovarian pregnancy n=2; 6.7%). Abdominal pain was the most common presenting symptom, present in 23 (76.7% patients) followed by vaginal bleeding in 17 (56.7%) patients. Ten women were managed medically, ten required surgical treatment, and eight were managed with combined medical and surgical treatments; Two patients were managed expectantly. Patients in each treatment strategy did well and there were no deaths. One patient in the medical treatment group developed complications after one month and underwent subtotal hysterectomy.</p><p><strong>Conclusion: </strong>Patients with NTEP were presented with varying symptoms and signs depending upon the location of NTEP. The different currently available management options for NTEP seem to be effective and safe when carefully selected based on the clinical merits of each case.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2063-2068"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476138/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic accuracy of low dose CT-Scan abdomen in patients with clinical features of acute appendicitis. 低剂量腹部 CT 扫描对具有急性阑尾炎临床特征的患者的诊断准确性。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9862
Syed Jehanzeb Asim, Zubia Masood, Erum Soomro, Abdul Sami Qureshi

Background & objective: Acute appendicitis is one of the commonest causes of acute abdominal pain presenting to emergency department (ED) and Computerized Tomography scan (CT) is considered gold standard for its diagnosis. Internationally Low Dose Computerized Tomography scan (LDCT) in emergency department is recommended as a beneficial tool to diagnose acute appendicitis with less exposure to radiation and reduction in the rate of negative laparotomy. Local trials are needed to determine the diagnostic accuracy of LDCT as the first line imaging test for acute appendicitis. Our objective was to determine the diagnostic accuracy of LDCT as the first line imaging test for acute appendicitis.

Methods: An observational study was conducted over a sample of 147 patients presented with suspected acute appendicitis to the emergency department of Ziauddin University Hospital, Karachi from November 2018 till May 2019. Non-probability consecutive technique used. Aged ≥ 16 years presented in emergency department with the history (symptoms) and physical examination (Signs) suspecting acute appendicitis were included. Patients with contraindications to CT scan e.g. pregnant women. Patients with signs of Acute Peritonitis requiring immediate surgery. CT scan refused by the patient or patient's attendant were excluded. Histopathology was the gold standard in diagnosing acute appendicitis. The data was analyzed using open epi sample size calculator.

Results: One hundred forty six patients had positive findings on LDCT for acute appendicitis (99.3%) whereas only one patient had negative findings (0.7%). The sensitivity and specificity of LDCT for the detection of acute appendicitis were estimated as 96.45% and 16.67% by taking histopathology as gold standard. Negative predictive value (NPV) and positive predictive value (PPV) were estimated as 16.67% and 96.45% respectively. The overall accuracy of LDCT was 93.88%.

Conclusion: Our study showed that for diagnosing acute appendicitis, LDCT is harmless, fast and economical imaging modality and has diagnostic accuracy with decrease in radiation dose.

背景与目的:急性阑尾炎是急诊科(ED)最常见的急性腹痛病因之一,计算机断层扫描(CT)被认为是诊断急性阑尾炎的金标准。国际上推荐在急诊科使用低剂量计算机断层扫描(LDCT)作为诊断急性阑尾炎的有利工具,可减少辐射暴露,降低开腹手术的阴性率。需要在当地进行试验,以确定 LDCT 作为急性阑尾炎一线成像检查的诊断准确性。我们的目标是确定 LDCT 作为急性阑尾炎一线成像检查的诊断准确性:从 2018 年 11 月至 2019 年 5 月,我们在卡拉奇齐亚乌丁大学医院急诊科对 147 名疑似急性阑尾炎患者进行了抽样观察研究。采用非概率连续技术。年龄≥16岁、病史(症状)和体格检查(体征)均怀疑患有急性阑尾炎的急诊患者均被纳入其中。有 CT 扫描禁忌症的患者,如孕妇。有急性腹膜炎体征并需要立即手术的患者。病人或病人的护理人员拒绝 CT 扫描的病人除外。组织病理学是诊断急性阑尾炎的金标准。数据使用开放式 epi 样本量计算器进行分析:结果:146 名急性阑尾炎患者的 LDCT 检查结果呈阳性(99.3%),只有一名患者呈阴性(0.7%)。以组织病理学为金标准,LDCT 检测急性阑尾炎的敏感性和特异性分别为 96.45% 和 16.67%。阴性预测值(NPV)和阳性预测值(PPV)分别为 16.67% 和 96.45%。LDCT的总体准确率为93.88%:我们的研究表明,在诊断急性阑尾炎时,LDCT 是一种无害、快速、经济的成像方式,并且在降低辐射剂量的同时还具有诊断准确性。
{"title":"Diagnostic accuracy of low dose CT-Scan abdomen in patients with clinical features of acute appendicitis.","authors":"Syed Jehanzeb Asim, Zubia Masood, Erum Soomro, Abdul Sami Qureshi","doi":"10.12669/pjms.40.9.9862","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9862","url":null,"abstract":"<p><strong>Background & objective: </strong>Acute appendicitis is one of the commonest causes of acute abdominal pain presenting to emergency department (ED) and Computerized Tomography scan (CT) is considered gold standard for its diagnosis. Internationally Low Dose Computerized Tomography scan (LDCT) in emergency department is recommended as a beneficial tool to diagnose acute appendicitis with less exposure to radiation and reduction in the rate of negative laparotomy. Local trials are needed to determine the diagnostic accuracy of LDCT as the first line imaging test for acute appendicitis. Our objective was to determine the diagnostic accuracy of LDCT as the first line imaging test for acute appendicitis.</p><p><strong>Methods: </strong>An observational study was conducted over a sample of 147 patients presented with suspected acute appendicitis to the emergency department of Ziauddin University Hospital, Karachi from November 2018 till May 2019. Non-probability consecutive technique used. Aged ≥ 16 years presented in emergency department with the history (symptoms) and physical examination (Signs) suspecting acute appendicitis were included. Patients with contraindications to CT scan e.g. pregnant women. Patients with signs of Acute Peritonitis requiring immediate surgery. CT scan refused by the patient or patient's attendant were excluded. Histopathology was the gold standard in diagnosing acute appendicitis. The data was analyzed using open epi sample size calculator.</p><p><strong>Results: </strong>One hundred forty six patients had positive findings on LDCT for acute appendicitis (99.3%) whereas only one patient had negative findings (0.7%). The sensitivity and specificity of LDCT for the detection of acute appendicitis were estimated as 96.45% and 16.67% by taking histopathology as gold standard. Negative predictive value (NPV) and positive predictive value (PPV) were estimated as 16.67% and 96.45% respectively. The overall accuracy of LDCT was 93.88%.</p><p><strong>Conclusion: </strong>Our study showed that for diagnosing acute appendicitis, LDCT is harmless, fast and economical imaging modality and has diagnostic accuracy with decrease in radiation dose.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2052-2055"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency of Cerebral Aneurysm in patients with subarachnoid hemorrhage on CT Cerebral Angiography. 蛛网膜下腔出血患者通过 CT 脑血管造影检查发现脑动脉瘤的频率。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8653
Sana, Shaista Shoukat, Sumera Tabassum, Haania Shahbaz

Objective: To determine the frequency of cerebral aneurysm in patients with subarachnoid haemorrhage on CT cerebral angiography.

Methods: This prospective cross-sectional study was conducted at Department of Radiology, JPMC, Karachi from 5th June 2022 to 30th January 2023. Total 176 patients with subarachnoid haemorrhage irrespective of gender were selected. CT angiography of cerebral vessels was performed. Cerebral aneurysm was noted as per operational definition and recorded.

Results: Age range was from 18 to 60 years. Mean age was 39.516±6.77 years, Mean BMI 29.630±3.08 Kg/m2. and mean duration of symptoms was 7.721±2.40 days. Male patients were 80.1% and females were 19.9%. Cerebral aneurysm was observed in 91.4% female and 78.7% male patients. Aneurysmal percentage was slightly higher in younger (18-40 years) age group (84.2% vs 80.4%) as compared to older (40-60) age group but statistically not significant. Although total percentage of female was quite less 19.9% (n=35 vs n=141 male), in this lesser female percentage, aneurysmal detection was higher as compared to male gender (91.4% vs 78.7%). Distribution of aneurysms according to vessel involved was; 28.7% along anterior communicating artery, 28.3% related to middle cerebral artery and, 22.9% were along posterior communicating vessel. Rest was distributed among other vessels including tip of basilar artery.

Conclusion: In Our study aneurysms was seen 81.3% in patients of subarachnoid hemorrhage having CT angiography at our center in Karachi Pakistan.

目的:确定蛛网膜下腔出血患者在 CT 脑血管造影中出现脑动脉瘤的频率:确定蛛网膜下腔出血患者通过 CT 脑血管造影检查发现脑动脉瘤的频率:这项前瞻性横断面研究于 2022 年 6 月 5 日至 2023 年 1 月 30 日在卡拉奇 JPMC 放射科进行。共选取了 176 名蛛网膜下腔出血患者,不分性别。对脑血管进行 CT 血管造影。根据操作定义记录脑动脉瘤:年龄范围为 18 至 60 岁。平均年龄为(39.516±6.77)岁,平均体重指数为(29.630±3.08)Kg/m2,平均症状持续时间为(7.721±2.40)天。男性患者占 80.1%,女性患者占 19.9%。91.4%的女性患者和78.7%的男性患者出现脑动脉瘤。与年龄较大(40-60 岁)的患者相比,年龄较小(18-40 岁)的患者动脉瘤比例略高(84.2% 对 80.4%),但统计学意义不大。虽然女性的总比例较低,仅为 19.9%(35 人对 141 名男性),但在较低的女性比例中,动脉瘤的检出率却高于男性(91.4% 对 78.7%)。动脉瘤根据涉及的血管分布情况为:28.7%沿前交通动脉,28.3%与大脑中动脉有关,22.9%沿后交通动脉。其余分布在其他血管,包括基底动脉末端:在我们的研究中,81.3% 的蛛网膜下腔出血患者在巴基斯坦卡拉奇中心接受了 CT 血管造影检查。
{"title":"Frequency of Cerebral Aneurysm in patients with subarachnoid hemorrhage on CT Cerebral Angiography.","authors":"Sana, Shaista Shoukat, Sumera Tabassum, Haania Shahbaz","doi":"10.12669/pjms.40.9.8653","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8653","url":null,"abstract":"<p><strong>Objective: </strong>To determine the frequency of cerebral aneurysm in patients with subarachnoid haemorrhage on CT cerebral angiography.</p><p><strong>Methods: </strong>This prospective cross-sectional study was conducted at Department of Radiology, JPMC, Karachi from 5<sup>th</sup> June 2022 to 30<sup>th</sup> January 2023. Total 176 patients with subarachnoid haemorrhage irrespective of gender were selected. CT angiography of cerebral vessels was performed. Cerebral aneurysm was noted as per operational definition and recorded.</p><p><strong>Results: </strong>Age range was from 18 to 60 years. Mean age was 39.516±6.77 years, Mean BMI 29.630±3.08 Kg/m2. and mean duration of symptoms was 7.721±2.40 days. Male patients were 80.1% and females were 19.9%. Cerebral aneurysm was observed in 91.4% female and 78.7% male patients. Aneurysmal percentage was slightly higher in younger (18-40 years) age group (84.2% vs 80.4%) as compared to older (40-60) age group but statistically not significant. Although total percentage of female was quite less 19.9% (n=35 vs n=141 male), in this lesser female percentage, aneurysmal detection was higher as compared to male gender (91.4% vs 78.7%). Distribution of aneurysms according to vessel involved was; 28.7% along anterior communicating artery, 28.3% related to middle cerebral artery and, 22.9% were along posterior communicating vessel. Rest was distributed among other vessels including tip of basilar artery.</p><p><strong>Conclusion: </strong>In Our study aneurysms was seen 81.3% in patients of subarachnoid hemorrhage having CT angiography at our center in Karachi Pakistan.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1975-1978"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476174/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron overload and liver function in patients with beta thalassemia major: A cross sectional study. 重型地中海贫血患者的铁超载和肝功能:一项横断面研究。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8961
Amna Faruqi, Tooba Zafar, Sikander Subuctageen, Irfan Afzal Mughal

Objective: In thalassemia major, repeated blood transfusions result in iron overload causing organ damage. The objective of this study was assessment of liver enzymes in patients with Thalassemia major and to observe their association with ferritin.

Method: A cross-sectional study was performed, at Islamabad Medical and Dental College and its affiliated Akbar Niazi Teaching Hospital from November 2021 till August 2022. Serum ferritin, AST, ALT, and total bilirubin levels were determined, in 135 patients of beta thalassemia major receiving transfusions. Data analysis was performed using SPSS Version 20. For categorical variables, calculation of frequencies and percentages was performed. Mean (± standard deviation) was determined for quantitative variables. ANOVA with post hoc Tukey's test was used for determining association between liver enzymes and serum ferritin. A p-value of <0.05 was considered significant. The correlation between ferritin and LFTs was determined by Pearson's correlation coefficient.

Results: Patients had an age range of 7-30 years, and males constituted 51% of sample. Mean level of ferritin was 6062.61 + 3641.79 ng/ml, with an insignificant difference between the genders (p =0.366). The levels of AST, ALT and bilirubin were perceived to show a significant increase in patients with ferritin levels >5000ng/ml, when compared with patients having ferritin levels < 2,500 ng/ml. A significant positive correlation of increasing serum ferritin levels was observed with ALT (r= 0.682), to a lesser extent with AST (r = 0.532), and only a weak correlation with serum bilirubin (r = 0.350).

Conclusion: Liver damage was caused by increased iron deposition. LFTs should be performed regularly to detect and reduce liver damage by increasing chelation therapy, thereby reducing morbidity and mortality due to thalassemia.

目的:重型地中海贫血患者反复输血会导致铁超载,造成器官损伤。本研究旨在评估重型地中海贫血患者的肝酶,并观察其与铁蛋白的关系:方法:2021 年 11 月至 2022 年 8 月,在伊斯兰堡医学和牙科学院及其附属阿克巴尔-尼亚齐教学医院进行了一项横断面研究。研究测定了 135 名接受输血的重型地中海贫血患者的血清铁蛋白、谷草转氨酶、谷丙转氨酶和总胆红素水平。数据分析采用 SPSS 20 版进行。对于分类变量,计算频率和百分比。定量变量采用平均值(± 标准差)。在确定肝酶与血清铁蛋白之间的关系时,采用方差分析和事后 Tukey 检验。结果患者年龄在 7-30 岁之间,男性占样本的 51%。铁蛋白的平均水平为 6062.61 + 3641.79 纳克/毫升,性别差异不显著(P =0.366)。与铁蛋白水平小于 2,500 ng/ml 的患者相比,铁蛋白水平大于 5,000ng/ml 的患者的谷草转氨酶、谷丙转氨酶和胆红素水平明显升高。血清铁蛋白水平的升高与谷丙转氨酶呈明显的正相关(r= 0.682),与谷草转氨酶的相关性较小(r= 0.532),与血清胆红素的相关性较弱(r= 0.350):结论:肝损伤是由铁沉积增加引起的。结论:肝脏损伤是由铁沉积增加引起的,应定期进行 LFT 检测,通过增加螯合疗法来发现和减少肝脏损伤,从而降低地中海贫血的发病率和死亡率。
{"title":"Iron overload and liver function in patients with beta thalassemia major: A cross sectional study.","authors":"Amna Faruqi, Tooba Zafar, Sikander Subuctageen, Irfan Afzal Mughal","doi":"10.12669/pjms.40.9.8961","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8961","url":null,"abstract":"<p><strong>Objective: </strong>In thalassemia major, repeated blood transfusions result in iron overload causing organ damage. The objective of this study was assessment of liver enzymes in patients with Thalassemia major and to observe their association with ferritin.</p><p><strong>Method: </strong>A cross-sectional study was performed, at Islamabad Medical and Dental College and its affiliated Akbar Niazi Teaching Hospital from November 2021 till August 2022. Serum ferritin, AST, ALT, and total bilirubin levels were determined, in 135 patients of beta thalassemia major receiving transfusions. Data analysis was performed using SPSS Version 20. For categorical variables, calculation of frequencies and percentages was performed. Mean (± standard deviation) was determined for quantitative variables. ANOVA with post hoc Tukey's test was used for determining association between liver enzymes and serum ferritin. A p-value of <0.05 was considered significant. The correlation between ferritin and LFTs was determined by Pearson's correlation coefficient.</p><p><strong>Results: </strong>Patients had an age range of 7-30 years, and males constituted 51% of sample. Mean level of ferritin was 6062.61 + 3641.79 ng/ml, with an insignificant difference between the genders (<i>p</i> =0.366). The levels of AST, ALT and bilirubin were perceived to show a significant increase in patients with ferritin levels >5000ng/ml, when compared with patients having ferritin levels < 2,500 ng/ml. A significant positive correlation of increasing serum ferritin levels was observed with ALT (r= 0.682), to a lesser extent with AST (r = 0.532), and only a weak correlation with serum bilirubin (r = 0.350).</p><p><strong>Conclusion: </strong>Liver damage was caused by increased iron deposition. LFTs should be performed regularly to detect and reduce liver damage by increasing chelation therapy, thereby reducing morbidity and mortality due to thalassemia.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2000-2004"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Report of incomplete intestinal obstruction in an adult patient with Down Syndrome: A literature review. 唐氏综合征成年患者不完全肠梗阻的报告:文献综述。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8777
Ning Yang

We report a case of incomplete intestinal obstruction in a 29-year-old adult male with Down syndrome in The First Affiliated Hospital, Hebei Medical University from January 2023 to July 2023 the patient had been experiencing intermittent abdominal distension and reduced bowel movements and gas for a period of two years. Physical examination revealed tenderness in the left lower abdomen. Abdominal CT and gastrointestinal imaging showed intestinal and colonic distension, while colonoscopy did not show any abnormalities. During laparoscopic exploration, adhesions were observed between the greater omentum and the left lower abdominal wall, resulting in dilation of the proximal colon. After the adhesions were released, intestinal contents were able to pass through the distal segment, relieving the obstruction. The patient had no history of trauma or surgery. This case highlights a potential association between Down syndrome and congenital abdominal adhesions that can lead to intestinal obstruction. Due to the communication difficulties in patients with Down syndrome, there is a potential for misdiagnosis, emphasizing the importance of awareness. Laparoscopic examination not only aids in the diagnosis but also offers therapeutic benefits in such cases.

我们报告了河北医科大学第一附属医院的一例不完全性肠梗阻病例,患者是一名患有唐氏综合征的 29 岁成年男性,从 2023 年 1 月到 2023 年 7 月,患者出现间歇性腹胀、肠蠕动减少和排气症状已有两年时间。体格检查发现左下腹有压痛。腹部 CT 和胃肠造影显示肠道和结肠胀气,结肠镜检查未见异常。腹腔镜探查时,发现大网膜和左下腹壁之间有粘连,导致近端结肠扩张。粘连松解后,肠内容物得以通过远端部分,解除了梗阻。患者无外伤或手术史。本病例强调了唐氏综合症与先天性腹腔粘连之间的潜在联系,这种粘连可导致肠梗阻。由于唐氏综合症患者沟通困难,因此有可能被误诊,这就强调了提高认识的重要性。在这种情况下,腹腔镜检查不仅有助于诊断,还能提供治疗效果。
{"title":"Report of incomplete intestinal obstruction in an adult patient with Down Syndrome: A literature review.","authors":"Ning Yang","doi":"10.12669/pjms.40.9.8777","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8777","url":null,"abstract":"<p><p>We report a case of incomplete intestinal obstruction in a 29-year-old adult male with Down syndrome in The First Affiliated Hospital, Hebei Medical University from January 2023 to July 2023 the patient had been experiencing intermittent abdominal distension and reduced bowel movements and gas for a period of two years. Physical examination revealed tenderness in the left lower abdomen. Abdominal CT and gastrointestinal imaging showed intestinal and colonic distension, while colonoscopy did not show any abnormalities. During laparoscopic exploration, adhesions were observed between the greater omentum and the left lower abdominal wall, resulting in dilation of the proximal colon. After the adhesions were released, intestinal contents were able to pass through the distal segment, relieving the obstruction. The patient had no history of trauma or surgery. This case highlights a potential association between Down syndrome and congenital abdominal adhesions that can lead to intestinal obstruction. Due to the communication difficulties in patients with Down syndrome, there is a potential for misdiagnosis, emphasizing the importance of awareness. Laparoscopic examination not only aids in the diagnosis but also offers therapeutic benefits in such cases.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2152-2155"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476137/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of mobile health applications (mHealth apps) in reshaping the body weight for better healthcare: A cross-sectional study. 移动医疗应用程序(mHealth apps)在重塑体重以改善医疗保健方面的作用:一项横断面研究。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9064
Moath Mohammed Albarrak, Nasriah Zakaria, Sultan Ayoub Meo

Objectives: Obesity is a chronic, multifaceted, leading health problem causing numerous non-communicable diseases with a huge burden on the global healthcare system and economies. Worldwide, multiple interventions have been familiarized for weight reduction strategies, however, in recent years, mobile health applications (mHealth apps) for reshaping weight reduction have been introduced. Therefore, this study aimed to investigate the role of mobile health applications in reducing weight among users in Riyadh, Saudi Arabia.

Methods: This questionnaire-based cross-sectional study was conducted in the Department of Family and Community Medicine, and Medical Education, College of Medicine, King Saud University, Riyadh from May 2019 to December 2022. A total of 502 participants, 332 (66.1%) females and 170 (33.9%) males aged 18-50 years, using smartphones, residing in Riyadh, Saudi Arabia were recruited. The questionnaire was distributed via social media platforms including WhatsApp, and emails and information were recorded.

Results: Among 502 participants, 221 (44.02%) were using mobile health applications and 281 (55.98%) did not use mobile health applications. The results revealed that the participants who have been using mHealth apps for the last six months had significantly decreased body weight compared to those who did not use the mHealth apps (p=0.001).

Conclusions: The study participants using mobile health applications (mHealth apps) had significantly reduced their body weight and felt healthier. The mHealth apps provide health-related information regularly to individuals to track their weight, monitor diet, and physical activity, and information about their overall health.

目标:肥胖症是一种慢性、多方面、主要的健康问题,可导致多种非传染性疾病,给全球医疗保健系统和经济造成巨大负担。在世界范围内,人们已经熟悉了多种减轻体重的干预策略,然而,近年来,用于减轻体重的移动医疗应用程序(mHealth apps)也被引入。因此,本研究旨在调查移动医疗应用程序在减轻沙特阿拉伯利雅得用户体重方面的作用:这项基于问卷的横断面研究于 2019 年 5 月至 2022 年 12 月在利雅得沙特国王大学医学院家庭与社区医学系和医学教育系进行。共招募了 502 名参与者,其中女性 332 人(66.1%),男性 170 人(33.9%),年龄在 18-50 岁之间,使用智能手机,居住在沙特阿拉伯利雅得。问卷通过包括 WhatsApp 在内的社交媒体平台发放,并记录了电子邮件和信息:在 502 名参与者中,221 人(44.02%)使用移动医疗应用程序,281 人(55.98%)未使用移动医疗应用程序。结果显示,与未使用移动健康应用程序的参与者相比,在过去六个月中一直使用移动健康应用程序的参与者体重明显下降(P=0.001):结论:使用移动保健应用程序(mHealth apps)的研究参与者体重明显减轻,感觉更加健康。移动保健应用程序定期向个人提供与健康相关的信息,以跟踪体重、监测饮食、体育锻炼以及有关其整体健康的信息。
{"title":"The role of mobile health applications (mHealth apps) in reshaping the body weight for better healthcare: A cross-sectional study.","authors":"Moath Mohammed Albarrak, Nasriah Zakaria, Sultan Ayoub Meo","doi":"10.12669/pjms.40.9.9064","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9064","url":null,"abstract":"<p><strong>Objectives: </strong>Obesity is a chronic, multifaceted, leading health problem causing numerous non-communicable diseases with a huge burden on the global healthcare system and economies. Worldwide, multiple interventions have been familiarized for weight reduction strategies, however, in recent years, mobile health applications (mHealth apps) for reshaping weight reduction have been introduced. Therefore, this study aimed to investigate the role of mobile health applications in reducing weight among users in Riyadh, Saudi Arabia.</p><p><strong>Methods: </strong>This questionnaire-based cross-sectional study was conducted in the Department of Family and Community Medicine, and Medical Education, College of Medicine, King Saud University, Riyadh from May 2019 to December 2022. A total of 502 participants, 332 (66.1%) females and 170 (33.9%) males aged 18-50 years, using smartphones, residing in Riyadh, Saudi Arabia were recruited. The questionnaire was distributed via social media platforms including WhatsApp, and emails and information were recorded.</p><p><strong>Results: </strong>Among 502 participants, 221 (44.02%) were using mobile health applications and 281 (55.98%) did not use mobile health applications. The results revealed that the participants who have been using mHealth apps for the last six months had significantly decreased body weight compared to those who did not use the mHealth apps (p=0.001).</p><p><strong>Conclusions: </strong>The study participants using mobile health applications (mHealth apps) had significantly reduced their body weight and felt healthier. The mHealth apps provide health-related information regularly to individuals to track their weight, monitor diet, and physical activity, and information about their overall health.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1930-1936"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative observation between Roxithromycin and Azithromycin sequential therapy in the treatment of Mycoplasma pneumoniae Pneumonia in Children. 罗红霉素和阿奇霉素序贯疗法在治疗儿童肺炎支原体肺炎中的比较观察。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.8942
Dan Liu, Yi-Fei Zhang

Objective: To investigate the clinical efficacy of roxithromycin combined with azithromycin sequential therapy in the treatment of mycoplasma pneumoniae pneumonia in children.

Methods: A retrospective study was conducted on 100 patients with mycoplasma pneumoniae pneumonia admitted to The First Affiliated Hospital of Yangtze University from January 2020 to December 2022. All patients were divided into the observation group (roxithromycin combined with azithromycin sequential therapy) and the control group (azithromycin sequential therapy), with 50 cases in each group. The clinical efficacy, improvement time of clinical symptoms/signs, inflammation indexes, oxidative stress indexes and immune function levels of the two groups were compared. Moreover, the improvement of lung function indexes and the adverse reactions were observed.

Results: The overall response rate of the observation group was 96.00%, which was higher than the control group (84.00%) (p<0.05). The time of clinical symptoms/signs in the observation group were significantly lower than those in the control group(p<0.05). After treatment, significant improvements were seen in the levels of CRP, TNF-ɑ, IL-6, GSH-Px, SOD, MDA, CD3+, CD4+, CD4+/CD8+, IgM, IgG , IgA, FEV1, FEV1%, FVC and FEV1/FVC of the two groups compared with those before treatment (p<0.05), and the improvement in the observation group was more obvious than that in the control group(p<0.05). The overall incidence of adverse reactions in the observation group was 6.00%, which was slightly lower than that in the control group (8.00%) (c²=0.154, P=0.695).

Conclusion: Roxithromycin combined with azithromycin sequential therapy is a safe regimen for the treatment of mycoplasma pneumoniae pneumonia in children.

目的:探讨罗红霉素联合阿奇霉素序贯疗法治疗儿童肺炎支原体肺炎的临床疗效:探讨罗红霉素联合阿奇霉素序贯疗法治疗儿童肺炎支原体肺炎的临床疗效:对2020年1月至2022年12月期间长江大学附属第一医院收治的100例肺炎支原体肺炎患者进行回顾性研究。将所有患者分为观察组(罗红霉素联合阿奇霉素序贯疗法)和对照组(阿奇霉素序贯疗法),每组50例。比较两组的临床疗效、临床症状/体征改善时间、炎症指标、氧化应激指标和免疫功能水平。此外,还观察了肺功能指标的改善情况和不良反应:观察组的总体反应率为 96.00%,高于对照组(84.00%)(P0.05)。观察组出现临床症状/体征的时间明显低于对照组(P0.05)。治疗后,两组的 CRP、TNF-ɑ、IL-6、GSH-Px、SOD、MDA、CD3+、CD4+、CD4+/CD8+、IgM、IgG、IgA、FEV1、FEV1%、FVC、FEV1/FVC 水平与治疗前相比均有明显改善(P0.05),且观察组的改善比对照组更明显(P0.05)。观察组不良反应总发生率为6.00%,略低于对照组的8.00%(c²=0.154,P=0.695):罗红霉素联合阿奇霉素序贯疗法是治疗儿童肺炎支原体肺炎的安全方案。
{"title":"Comparative observation between Roxithromycin and Azithromycin sequential therapy in the treatment of Mycoplasma pneumoniae Pneumonia in Children.","authors":"Dan Liu, Yi-Fei Zhang","doi":"10.12669/pjms.40.9.8942","DOIUrl":"https://doi.org/10.12669/pjms.40.9.8942","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the clinical efficacy of roxithromycin combined with azithromycin sequential therapy in the treatment of mycoplasma pneumoniae pneumonia in children.</p><p><strong>Methods: </strong>A retrospective study was conducted on 100 patients with mycoplasma pneumoniae pneumonia admitted to The First Affiliated Hospital of Yangtze University from January 2020 to December 2022. All patients were divided into the observation group (roxithromycin combined with azithromycin sequential therapy) and the control group (azithromycin sequential therapy), with 50 cases in each group. The clinical efficacy, improvement time of clinical symptoms/signs, inflammation indexes, oxidative stress indexes and immune function levels of the two groups were compared. Moreover, the improvement of lung function indexes and the adverse reactions were observed.</p><p><strong>Results: </strong>The overall response rate of the observation group was 96.00%, which was higher than the control group (84.00%) (<i>p<</i>0.05). The time of clinical symptoms/signs in the observation group were significantly lower than those in the control group(<i>p<</i>0.05). After treatment, significant improvements were seen in the levels of CRP, TNF-ɑ, IL-6, GSH-Px, SOD, MDA, CD3<sup>+</sup>, CD4<sup>+</sup>, CD4<sup>+</sup>/CD8<sup>+</sup>, IgM, IgG , IgA, FEV<sub>1</sub>, FEV<sub>1</sub>%, FVC and FEV<sub>1</sub>/FVC of the two groups compared with those before treatment (<i>p<</i>0.05), and the improvement in the observation group was more obvious than that in the control group(<i>p<</i>0.05). The overall incidence of adverse reactions in the observation group was 6.00%, which was slightly lower than that in the control group (8.00%) (c²=0.154, <i>P</i>=0.695).</p><p><strong>Conclusion: </strong>Roxithromycin combined with azithromycin sequential therapy is a safe regimen for the treatment of mycoplasma pneumoniae pneumonia in children.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2124-2129"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia. 在针刺麻醉下接受消化道内窥镜检查的患者出现并发症的风险因素。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.10087
Haoliang Cai, Xiaohui Wu, Xi Chen, Jun Guo, Wenting Chen

Objective: To identify risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia and to construct a nomogram predictive model.

Methods: This retrospective study included 292 patients who underwent gastrointestinal endoscopy under acupuncture anesthesia at the Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from June 2020 to May 2023. Logistic regression analysis was used to identify risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia. A nomogram prediction model was constructed using the RMS package of R4.1.2 software based on the independent risk factors identified. The predictive performance of the model was assessed using consistency index (C-index), calibration curve, and receiver operating characteristic (ROC) curve.

Results: Seventy-five patients (25.68%) had complications. Body mass index (BMI), history of cardiovascular diseases, fasting time, history of respiratory diseases, and Sedation-Agitation Scale (SAS) score were identified as risk factors for complications. Based on this risk, a nomogram predictive model was constructed. The C-index of the nomogram model was 0.927. Calibration curve showed a good consistency between actual observations and nomogram predictions. The ROC curve area under curve (AUC) was 0.927 (95% CI: 0.895-0.959), indicating a certain predictive value for the occurrence of complications. When the optimal cut-off value was selected, the sensitivity and specificity of the model were 77.0% and 92.0%, respectively, indicating that the predictive model was effective.

Conclusions: BMI, history of cardiovascular disease, fasting time, history of respiratory disease, and SAS score are independent risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia. The constructed nomogram predictive model has a good performance in predicting the occurrence of complications in patients undergoing gastrointestinal endoscopy with under acupuncture anesthesia.

目的确定在针刺麻醉下接受消化道内镜检查的患者出现并发症的风险因素,并构建一个提名图预测模型:这项回顾性研究纳入了2020年6月至2023年5月期间在上海中医药大学附属曙光医院接受针灸麻醉下消化内镜检查的292例患者。采用逻辑回归分析法确定在针刺麻醉下接受消化内镜检查的患者出现并发症的风险因素。根据识别出的独立风险因素,使用R4.1.2软件的RMS包构建了一个提名图预测模型。使用一致性指数(C-index)、校准曲线和接收者操作特征曲线(ROC)评估了该模型的预测性能:75名患者(25.68%)出现并发症。体重指数(BMI)、心血管疾病史、空腹时间、呼吸系统疾病史和镇静-镇静量表(SAS)评分被确定为并发症的风险因素。根据这些风险因素,构建了一个提名图预测模型。提名图模型的 C 指数为 0.927。校准曲线显示实际观察结果与提名图预测结果之间具有良好的一致性。ROC 曲线下面积(AUC)为 0.927(95% CI:0.895-0.959),表明对并发症的发生有一定的预测价值。当选择最佳临界值时,模型的灵敏度和特异度分别为 77.0% 和 92.0%,表明该预测模型是有效的:结论:体重指数、心血管疾病史、空腹时间、呼吸系统疾病史和SAS评分是在针刺麻醉下接受消化内镜检查的患者出现并发症的独立风险因素。所构建的提名图预测模型在预测针刺麻醉下接受消化道内窥镜检查的患者发生并发症方面具有良好的性能。
{"title":"Risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia.","authors":"Haoliang Cai, Xiaohui Wu, Xi Chen, Jun Guo, Wenting Chen","doi":"10.12669/pjms.40.9.10087","DOIUrl":"https://doi.org/10.12669/pjms.40.9.10087","url":null,"abstract":"<p><strong>Objective: </strong>To identify risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia and to construct a nomogram predictive model.</p><p><strong>Methods: </strong>This retrospective study included 292 patients who underwent gastrointestinal endoscopy under acupuncture anesthesia at the Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from June 2020 to May 2023. Logistic regression analysis was used to identify risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia. A nomogram prediction model was constructed using the RMS package of R4.1.2 software based on the independent risk factors identified. The predictive performance of the model was assessed using consistency index (C-index), calibration curve, and receiver operating characteristic (ROC) curve.</p><p><strong>Results: </strong>Seventy-five patients (25.68%) had complications. Body mass index (BMI), history of cardiovascular diseases, fasting time, history of respiratory diseases, and Sedation-Agitation Scale (SAS) score were identified as risk factors for complications. Based on this risk, a nomogram predictive model was constructed. The C-index of the nomogram model was 0.927. Calibration curve showed a good consistency between actual observations and nomogram predictions. The ROC curve area under curve (AUC) was 0.927 (95% CI: 0.895-0.959), indicating a certain predictive value for the occurrence of complications. When the optimal cut-off value was selected, the sensitivity and specificity of the model were 77.0% and 92.0%, respectively, indicating that the predictive model was effective.</p><p><strong>Conclusions: </strong>BMI, history of cardiovascular disease, fasting time, history of respiratory disease, and SAS score are independent risk factors for complications in patients undergoing gastrointestinal endoscopy under acupuncture anesthesia. The constructed nomogram predictive model has a good performance in predicting the occurrence of complications in patients undergoing gastrointestinal endoscopy with under acupuncture anesthesia.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2022-2027"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of different tirofiban administration times in patients with no-reflow myocardial infarction during percutaneous coronary intervention. 经皮冠状动脉介入治疗过程中不同替罗非班给药时间对无回流心肌梗死患者的效果。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.10101
Chaosheng Mei, Huiping Yu

Objective: To compare the effectiveness of different tirofiban administration time windows in patients with no-reflow myocardial infarction (MI) during percutaneous coronary intervention (PCI).

Methods: This single centre retrospective observational study included patients with no-reflow MI, undergoing PCI at the Hanyang Hospital affiliated to Wuhan University of Science and Technology from March 2020 to May 2023. All patients were administered tirofiban. Patients who received tirofiban with postinterventional thrombolysis in myocardial infarction (TIMI) flow ≥ 1 were grouped as Group-I, and patients who were directly given tirofiban through the guiding catheter without forward blood flow were grouped as Group-II. TIMI blood flow classification, levels of cardiac troponin T (cTnT) and creatine kinase isoenzyme MB (CK-MB), incidence of complications and major adverse cardiovascular events (MACE) in the two groups before and after the treatment were statistically analyzed.

Results: A total of 156 patients were included in this study, including 79 patients in Group-I and 77 patients in Group-II. There was no significant difference in the baseline data between the two groups (P>0.05). After treatment, TIMI blood flow classification of the two groups improved and was significantly better in Group-I compared to Group-II (P<0.05). After treatment, levels of Serum cTnT and CK-MB in the two groups decreased, and were significantly lower in Group-I than in Group-II (P<0.05). There was no significant difference in the incidence of complications between Group-I (3.80%) and Group-II (6.49%) (P>0.05). The incidence of MACE in Group-I (3.80%) was lower than that in Group-II (12.99%) (P<0.05).

Conclusions: Compared with the direct application of tirofiban, tirofiban given when TIMI Grade≥ 1 for patients with no-reflow MI during PCI can more effectively regulate the blood flow status of target vessels, reduce myocardial injury, and reduce the risk of MACE.

目的比较经皮冠状动脉介入治疗(PCI)过程中不同替罗非班给药时间窗对无复流心肌梗死(MI)患者的有效性:这项单中心回顾性观察研究纳入了2020年3月至2023年5月期间在武汉科技大学附属汉阳医院接受PCI治疗的无回流心肌梗死患者。所有患者均接受了替罗非班治疗。接受介入后心肌梗死溶栓(TIMI)血流≥1的患者为Ⅰ组,通过导引导管直接给予替罗非班而无前向血流的患者为Ⅱ组。对两组患者治疗前后的 TIMI 血流分级、心肌肌钙蛋白 T(cTnT)和肌酸激酶同工酶 MB(CK-MB)水平、并发症发生率和主要不良心血管事件(MACE)进行统计分析:本研究共纳入 156 例患者,其中第一组 79 例,第二组 77 例。两组患者的基线数据无明显差异(P>0.05)。治疗后,两组患者的 TIMI 血流分级均有所改善,I 组明显优于 II 组(PPP>0.05)。Ⅰ组的 MACE 发生率(3.80%)低于Ⅱ组(12.99%)(PConclusions:与直接应用替罗非班相比,PCI过程中对无复流心肌梗死患者在TIMI≥1级时给予替罗非班能更有效地调节靶血管血流状态,减少心肌损伤,降低MACE风险。
{"title":"Effectiveness of different tirofiban administration times in patients with no-reflow myocardial infarction during percutaneous coronary intervention.","authors":"Chaosheng Mei, Huiping Yu","doi":"10.12669/pjms.40.9.10101","DOIUrl":"https://doi.org/10.12669/pjms.40.9.10101","url":null,"abstract":"<p><strong>Objective: </strong>To compare the effectiveness of different tirofiban administration time windows in patients with no-reflow myocardial infarction (MI) during percutaneous coronary intervention (PCI).</p><p><strong>Methods: </strong>This single centre retrospective observational study included patients with no-reflow MI, undergoing PCI at the Hanyang Hospital affiliated to Wuhan University of Science and Technology from March 2020 to May 2023. All patients were administered tirofiban. Patients who received tirofiban with postinterventional thrombolysis in myocardial infarction (TIMI) flow ≥ 1 were grouped as Group-I, and patients who were directly given tirofiban through the guiding catheter without forward blood flow were grouped as Group-II. TIMI blood flow classification, levels of cardiac troponin T (cTnT) and creatine kinase isoenzyme MB (CK-MB), incidence of complications and major adverse cardiovascular events (MACE) in the two groups before and after the treatment were statistically analyzed.</p><p><strong>Results: </strong>A total of 156 patients were included in this study, including 79 patients in Group-I and 77 patients in Group-II. There was no significant difference in the baseline data between the two groups (P>0.05). After treatment, TIMI blood flow classification of the two groups improved and was significantly better in Group-I compared to Group-II (<i>P</i><0.05). After treatment, levels of Serum cTnT and CK-MB in the two groups decreased, and were significantly lower in Group-I than in Group-II (<i>P</i><0.05). There was no significant difference in the incidence of complications between Group-I (3.80%) and Group-II (6.49%) (<i>P</i>>0.05). The incidence of MACE in Group-I (3.80%) was lower than that in Group-II (12.99%) (<i>P</i><0.05).</p><p><strong>Conclusions: </strong>Compared with the direct application of tirofiban, tirofiban given when TIMI Grade≥ 1 for patients with no-reflow MI during PCI can more effectively regulate the blood flow status of target vessels, reduce myocardial injury, and reduce the risk of MACE.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"1969-1974"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC. 氩氦冷冻消融联合化疗治疗晚期 NSCLC 的疗效。
IF 1.2 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-01 DOI: 10.12669/pjms.40.9.9882
Yongfei Guo, Jing Yan, Mao Yang, Tongguo Si

Objective: To explore the efficacy of argon-helium cryoablation (AHC) combined with chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Methods: A retrospective study was carried out between February 2020 to June 2022 of 85 patients with advanced NSCLC admitted to Tianjin Cancer Hospital Airport Hospital. Patients were categorized into two groups based on whether they had received AHC: patients received chemotherapy treatment alone (chemotherapy group, n=41); patients received chemotherapy combined with AHC (combined group, n=44). Tumor control rate, serum tumor marker levels, quality of life, and median survival time between the two groups were compared.

Results: Tumor control rate in the combined group (86.36%) was significantly higher than that in the chemotherapy group (68.29%) (P<0.05). After treatment, the levels of serum cytokeratin 19 fragment (CYFRA21-1), carcinoembryonic antigen (CEA) and glycoprotein antigen 125 (CA125) in the two groups were significantly lower than those before the treatment, and significantly lower in the combined group compared to the chemotherapy group (P<0.05). After the treatment, the quality of life of patients in both groups was significantly higher than before the treatment. Quality of life in the combined group was significantly higher than in the chemotherapy group (P<0.05). One year after treatment, the median survival time of the combined group (10.5 months; 95% CI: 9.775-11.225) was significantly higher than that of the chemotherapy group (9.4 months; 95% CI: 8.55-10.323) (P=0.045).

Conclusions: Compared with chemotherapy alone, conventional chemotherapy combined with AHC in the treatment of advanced NSCLC can significantly reduce the levels of serum tumor markers and improve overall treatment efficacy, quality of life and 1-year overall survival rate.

目的探讨氩氦刀低温消融(AHC)联合化疗治疗晚期非小细胞肺癌(NSCLC)的疗效:2020年2月至2022年6月期间,对天津市肿瘤医院空港医院收治的85例晚期NSCLC患者进行了回顾性研究。根据患者是否接受过AHC治疗将其分为两组:单独接受化疗的患者(化疗组,41人);化疗联合AHC的患者(联合组,44人)。比较两组患者的肿瘤控制率、血清肿瘤标志物水平、生活质量和中位生存时间:结果:联合组的肿瘤控制率(86.36%)明显高于化疗组(68.29%)(PC结论:与单纯化疗相比,常规化疗联合 AHC 治疗的肿瘤控制率(86.36%)明显高于化疗组(68.29%):与单纯化疗相比,常规化疗联合AHC治疗晚期NSCLC可明显降低血清肿瘤标志物水平,提高总体疗效、生活质量和1年总生存率。
{"title":"Efficacy of argon-helium cryoablation combined with chemotherapy in the treatment of advanced NSCLC.","authors":"Yongfei Guo, Jing Yan, Mao Yang, Tongguo Si","doi":"10.12669/pjms.40.9.9882","DOIUrl":"https://doi.org/10.12669/pjms.40.9.9882","url":null,"abstract":"<p><strong>Objective: </strong>To explore the efficacy of argon-helium cryoablation (AHC) combined with chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>A retrospective study was carried out between February 2020 to June 2022 of 85 patients with advanced NSCLC admitted to Tianjin Cancer Hospital Airport Hospital. Patients were categorized into two groups based on whether they had received AHC: patients received chemotherapy treatment alone (chemotherapy group, n=41); patients received chemotherapy combined with AHC (combined group, n=44). Tumor control rate, serum tumor marker levels, quality of life, and median survival time between the two groups were compared.</p><p><strong>Results: </strong>Tumor control rate in the combined group (86.36%) was significantly higher than that in the chemotherapy group (68.29%) (P<0.05). After treatment, the levels of serum cytokeratin 19 fragment (CYFRA21-1), carcinoembryonic antigen (CEA) and glycoprotein antigen 125 (CA125) in the two groups were significantly lower than those before the treatment, and significantly lower in the combined group compared to the chemotherapy group (P<0.05). After the treatment, the quality of life of patients in both groups was significantly higher than before the treatment. Quality of life in the combined group was significantly higher than in the chemotherapy group (P<0.05). One year after treatment, the median survival time of the combined group (10.5 months; 95% CI: 9.775-11.225) was significantly higher than that of the chemotherapy group (9.4 months; 95% CI: 8.55-10.323) (P=0.045).</p><p><strong>Conclusions: </strong>Compared with chemotherapy alone, conventional chemotherapy combined with AHC in the treatment of advanced NSCLC can significantly reduce the levels of serum tumor markers and improve overall treatment efficacy, quality of life and 1-year overall survival rate.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 9","pages":"2017-2021"},"PeriodicalIF":1.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11476131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142472300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pakistan Journal of Medical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1